GLP-1 Drugs Linked to 35% Lower Risk of Breast Cancer Women taking GLP-1 drugs, including Ozempic, Wegovy, and Mounjaro, were around 30% less likely to develop breast cancer than peers not taking the drug
Neurodegenerative Conditions Potential for Cognitive Health : Amylin-related peptides, including cagrilintide, are being explored for their potential role in addressing Alzheimers disease and other neurodegenerative conditions, although this remains an area of emerging research ( 4 )
Reduced efficacy is the primary concern
Squamous cell carcinoma of the nail bed: a rare disease or only misdiagnosed
Improved Metabolic Health: In addition to weight loss, tirzepatide can improve other metabolic markers, such as lowering blood sugar levels and reducing triglycerides
Close monitoring and potentially simplified treatment regimens may be necessary as cognitive impairment progresses